A detailed history of Nisa Investment Advisors, LLC transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 315 shares of ANIP stock, worth $19,353. This represents 0.0% of its overall portfolio holdings.

Number of Shares
315
Previous 300 5.0%
Holding current value
$19,353
Previous $16,000 31.25%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$54.2 - $69.69 $813 - $1,045
15 Added 5.0%
315 $21,000
Q4 2023

Jan 25, 2024

BUY
$48.72 - $65.43 $194 - $261
4 Added 1.35%
300 $16,000
Q2 2023

Aug 11, 2023

BUY
$37.29 - $53.83 $223 - $322
6 Added 2.07%
296 $15,000
Q1 2022

Apr 29, 2022

SELL
$26.91 - $47.15 $32,830 - $57,523
-1,220 Reduced 80.79%
290 $8,000
Q4 2021

Feb 03, 2022

SELL
$32.97 - $56.85 $13,188 - $22,740
-400 Reduced 20.94%
1,510 $61,000
Q3 2021

Oct 18, 2021

SELL
$26.48 - $35.99 $2,648 - $3,599
-100 Reduced 4.98%
1,910 $63,000
Q2 2021

Aug 06, 2021

BUY
$31.86 - $38.6 $50,976 - $61,760
1,600 Added 390.24%
2,010 $70,000
Q4 2020

Jan 25, 2021

BUY
$23.69 - $31.47 $7,107 - $9,441
300 Added 272.73%
410 $12,000
Q2 2020

Jul 27, 2020

SELL
$29.93 - $50.1 $199,932 - $334,668
-6,680 Reduced 98.38%
110 $4,000
Q4 2019

Jan 17, 2020

BUY
$55.65 - $79.83 $204,235 - $292,976
3,670 Added 117.63%
6,790 $419,000
Q3 2019

Oct 17, 2019

SELL
$64.7 - $85.39 $289,079 - $381,522
-4,468 Reduced 58.88%
3,120 $227,000
Q1 2019

Apr 17, 2019

BUY
$45.83 - $70.54 $342,716 - $527,498
7,478 Added 6798.18%
7,588 $535,000
Q2 2018

Jul 19, 2018

SELL
$56.38 - $68.08 $163,502 - $197,432
-2,900 Reduced 96.35%
110 $7,000
Q1 2018

Apr 10, 2018

SELL
$56.98 - $72.41 $5,698 - $7,241
-100 Reduced 3.22%
3,010 $192,000
Q3 2017

Oct 13, 2017

BUY
$43.46 - $52.49 $135,160 - $163,243
3,110
3,110 $163,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $1.07B
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.